We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Measures biomarkers of lipid metabolism in response to a marginal zinc depletion, repletion and supplementation in healthy males
Globally, there has been a very small number of reports of new-onset or aggravation of pre-existing myasthenia gravis with atorvastatin, pravastatin, lovastatin, fluvastatin, simvastatin, rosuvastatin and pitavastatin (single-ingredient and fixed-dose combination products). Advise patients taking statins to be alert to...
Find out the information you must give to customers on food products and how to give it.
Information for patients, healthcare professionals and developers of new medicines
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Advice for medical professionals to follow when assessing drivers with diabetes mellitus.
How to use an economic evaluation to evaluate your digital health product.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
From brussels sprouts to dodgy diet products, these tips from the MHRA will help you stay safe during the festive season and beyond
These documents explain how OHID is approaching reduction and food and drink reformulation as part of the government’s obesity strategy.
Topical steroid products are safe and highly effective treatments for the management of a wide range of inflammatory skin diseases but have important risks, especially with prolonged use at high potency. In the coming months, as a result of regulatory...
How to use a cost benefit analysis to evaluate your digital health product.
What you can do to help reduce the risk of bovine tuberculosis (TB) infection in your herd.
Public health principles for reducing the spread of respiratory infections, including COVID-19, in the workplace.
A professional resource on improving the detection and treatment of the high-risk conditions atrial fibrillation, high blood pressure and high cholesterol
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).